Increasing use of cannabis among arrested drivers in Norway

References

• Australian Institute of Health and Welfare. Alcohol and Other Drug Treatment Services in Australia 2012–13. Canberra, Australia: Author; 2014a. Available at: http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=60129548257. Accessed August 15, 2016.
   Google Scholar
• Australian Institute of Health and Welfare. National Drug Strategy Household Survey—Detailed Report 2013. Canberra, Australia: Author; 2014b. Available at: http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=60129549848. Accessed August 15, 2016.
   Google Scholar
• Cascini F, Aiello C, Di Tanna G. Increasing delta-9-tetrahydrocannabinol (delta-9-THC) content in herbal cannabis over time: systematic review and meta-analysis. Curr Drug Abuse Rev. 2012;5:32–40.
   PubMedGoogle Scholar
• Christophersen AS, Skurtveit S, Grung M, Mørland J. Rearrest rates among Norwegian drunken drugged drivers compared with drivers. Drug Alcohol Depend. 2002;66:85–92.
   PubMed Web of Science ®Google Scholar
• Couper FJ, Peterson BL. The prevalence of marijuana in suspected impaired driving cases in Washington State. J Anal Toxicol. 2014;38:569–574.
   PubMed Web of Science ®Google Scholar
• Darnell AJ. I-502 Evaluation Plan and Preliminary Report on Implementation. Olympia, WA: Washington State Institute for Public Policy. Olympia, WA; 2015. Document Number 15-09-3201. Available at: http://www.wsipp.wa.gov/ReportFile/1616/Wsipp_I-502-Evaluation-Plan-and-Preliminary-Report-on-Implementation_Report.pdf. Acce-ssed August 15, 2016.
   Google Scholar
• Gmel G, Rehm J. The empirical testability of Skog's theory of collective drinking behaviour. Drug Alcohol Rev. 2000;19:391–399.
   PubMed Web of Science ®Google Scholar
• Hall W. What has research over the past two decades revealed about the adverse health effects of recreational cannabis use? Addiction. 2015;110:19–35.
   PubMed Web of Science ®Google Scholar
• Hartman RL, Brown TL, Milavetz G, et al. Effect of blood collection time on measured delta(9)-tetrahydrocannabinol concentrations: implications for driving interpretation and drug policy. Clin Chem. 2016;62:367–377.
   PubMed Web of Science ®Google Scholar
• Hartman RL, Brown TL, Milavetz G, et al. Cannabis effects on driving lateral control with and without alcohol. Drug Alcohol Depend. 2015;154:25–37.
   PubMed Web of Science ®Google Scholar
• Hoch E, Bonnetn U, Thomasius R, Ganzer F, Havemann-Reinecke U, Preuss UW. Risks associated with the non-medicinal use of cannabis. Dtsch Arztebl Int. 2015;112:271–278.
   PubMed Web of Science ®Google Scholar
• Huestis MA, Henningfield JE, Cone EJ. Blood Cannabinoids.1. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana. J Anal Toxicol. 1992;16(5):276–282.
   PubMed Web of Science ®Google Scholar
• Johnson TP. Sources of error in substance use prevalence surveys. Int Sch Res Notices. 2014;2014:923290.
   PubMedGoogle Scholar
• Kaar SJ, Gao CX, Lloyd B, Smith K, Lubman DI. Trends in cannabis-related ambulance presentations from 2000 to 2013 in Melbourne, Australia. Drug Alcohol Depend. 2015;155:24–30.
   PubMed Web of Science ®Google Scholar
• Kripos. Narkotika- og Dopingstatistikk 2016 [Drug seizure statistics 2016]. Oslo, Norway: The National Criminal Investigation Service. 2017. Available at: https://www.politi.no/vedlegg/lokale_vedlegg/kripos/Vedlegg_4409.pdf. Accessed February 22, 2017.
   Google Scholar
• Leifman H, Romelsjö A. The effect of changes in alcohol consumption on mortality and admissions with alcohol-related diagnoses in Stockholm County—a time series analysis. Addiction. 1997;92:1523–1536.
   PubMed Web of Science ®Google Scholar
• Logan B. Marijuana and driving impairment. In: ElSohly MA, ed. Forensic Science and Medicine: Marijuana and the Cannabinoids. Totowa, NJ: Humana Press; 2007:277–293.
   Google Scholar
• Lovdata. Forskrift om Endring i Forskrift om Faste Grenser for Påvirkning av Andre Berusende Eller Bedøvende Middel enn Alkohol m.m. (Forskrift om Faste Grenser) [Revision of fixed limits for drugs in the traffic]. Oslo, Norway: Ministry of Justice; 2016. Available at: https://lovdata.no/dokument/LTI/forskrift/2016-01-12-19. Accessed February 22, 2017.
   Google Scholar
• Mäkelä P. Whose drinking does the liberalization of alcohol policy increase? Change in alcohol consumption by the initial level in the Finnish panel survey in 1968 and 1969. Addiction. 2002;97:701–706.
   PubMed Web of Science ®Google Scholar
• Masten SV, Guenzburger GV. Changes in driver cannabinoid prevalence in 12 U.S. states after implementing medical marijuana laws. J Safety Res. 2014;50:35–52.
   PubMed Web of Science ®Google Scholar
• Moylan S, Giorlando F, Nordfjaern T, Berk M. The role of alprazolam for the treatment of panic disorder in Australia. Aust N Z J Psychiatry. 2012;46:212–224.
   PubMed Web of Science ®Google Scholar
• National Conference of State Legislatures. State Medical Marijuana Laws. Wasnington, DC: Author; 2016. Available at: http://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx. Accessed March 21, 2016.
   Google Scholar
• Papafotiou K, Carter JD, Stough C. The relationship between performance on the standardised field sobriety tests, driving performance and the level of delta 9-tetrahydrocannabinol (THC) in blood. Forensic Sci Int. 2005;155(2–3):172–178.
   PubMed Web of Science ®Google Scholar
• Ramaekers JG, Berghaus G, van Laar M, Drummer OH. Dose related risk of motor vehicle crashes after cannabis use: an update. In: Verster JC, Pandi-Perumal SR, Ramaekers JG, de Gier JJ, eds. Drugs, Driving and Traffic Safety. Basel, Switzerland: Birkhäuser Verlag; 2009:477–499.
   Google Scholar
• Rossow I, Bramness JG. The total sale of prescription drugs with an abuse potential predicts the number of excessive users: a national prescription database study. BMC Public Health. 2015;15:288.
   PubMed Web of Science ®Google Scholar
• Salomonsen-Sautel S, Min SJ, Sakai JT, Thurstone C, Hopfer C. Trends in fatal motor vehicle crashes before and after marijuana commercialization in Colorado. Drug Alcohol Depend. 2014;140:137–144.
   PubMed Web of Science ®Google Scholar
• Schwope DM, Bosker WM, Ramaekers JG, Gorelick DA, Huestis MA. Psychomotor performance, subjective and physiological effects and whole blood delta(9)-tetrahydrocannabinol concentrations in heavy, chronic cannabis smokers following acute smoked cannabis. J Anal Toxicol. 2012;36:405–412.
   PubMed Web of Science ®Google Scholar
• Skog OJ. The tail of the alcohol consumption distribution. Addiction. 1993;88:601–610.
   PubMed Web of Science ®Google Scholar
• Skretting A, Vedøy TF, Lund KE, Bye EK. Rusmidler i Norge 2016 [Drugs in Norway 2016]. Oslo, Norway: The Norwegian Institute of Public Health; 2016. Available at: https://www.fhi.no/globalassets/dokumenterfiler/rapporter/rusmidler_i_norge_2016.pdf. Accessed March 13, 2017.
   Google Scholar
• Vindenes V, Jordbru D, Knapskog A-B, et al. Impairment based legislative limits for driving under the influence of non-alcohol drugs in Norway. Forensic Sci Int. 2012;219(1–3):1–11.
   PubMed Web of Science ®Google Scholar
• Volkow ND, Swanson JM, Evins AE, et al. Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: a review. JAMA Psychiatry. 2016;73:292–297.
   PubMed Web of Science ®Google Scholar